During his Harvard-MIT MD/PhD program, Mark combined engineering, molecular biology, and bioinformatics approaches in the study of cancer diagnostics, metastasis, and longitudinal monitoring. Firsthand experience has helped him understand the challenges biologists face when trying to quickly and efficiently process and gain insights from their genomics data.